Effect of the composition of atherosclerotic plaques and rate of platelet aggregation on elevation of serum levels of cardiac troponin T after percutaneous coronary interventions

Journal of Interventional Cardiology

Volumn 25, Issue 5, 2012, Pages 433-438

  Zhao, Xiao Yan ^a   Wang, Xiao Fang ^a   Zhang, Jin Ying ^a   Du, You You ^a   Yang, Hai Bo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; TRIACYLGLYCEROL; TROPONIN T;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEART MUSCLE NECROSIS; HUMAN; HYPERTENSION; IMAGE ANALYSIS; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING; THROMBOCYTE AGGREGATION; UNSTABLE ANGINA PECTORIS;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; STATISTICS AS TOPIC; TIME FACTORS; TROPONIN T; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84867098576     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2012.00742.x     Document Type: Article

References (19)

1. Jeremias A, Kleiman NS, Nassif D, et al,. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: Results from the evaluation of drug eluting stents and ischemic events registry. Circulation 2008; 118: 632-638.
2. Napan S, Kashinath RC, Kadri S, et al,. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention. Coron Artery Dis 2010; 21: 261-265.
3. Gravning J, Ueland T, Mørkrid L, et al,. Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris. Scand Cardiovasc J 2008; 42: 214-221.
4. Feldman DN, Kim L, Rene AG, et al,. Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: A meta-analysis. Catheter Cardiovasc Interv 2011; 77: 1020-1030.
5. Rand ML, Leung R, Packham MA,. Platelet function assays. Transfus Apher Sci 2003; 28: 307-317.
6. Mintz GS, Nissen SE, Anderson WD, et al,. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. JACC 2001; 37: 1478-1492.
7. Shin ES, Garcia-Garcia HM, Serruys PW,. A new method to measure necrotic core and calcium content in coronary plaques using intravascular ultrasound radiofrequency-based analysis. Int J Cardiovasc Imaging 2010; 26: 387-396.
8. Nageh T, Sherwood RA, Harris BM, et al,. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease. Heart 2005; 91: 1181-1185.
9. Prasad A, Rihal CS, Lennon RJ, et al,. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: An analysis of preintervention and post intervention troponin T levels in 5487 patients. Circ Cardiovasc Interv 2008; 1: 10-19.
10. Nageh T, Sherwood RA, Harris BM, et al,. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol 2003; 92: 285-293.
11. Böse D, von Birgelen C, Zhou XY, et al,. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol 2008; 103: 587-597.
12. Hong YJ, Mintz GS, Kim SW, et al,. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: An ultrasound analysis. JACC Cardiovasc Imaging 2009; 2: 458-468.
13. Shin ES, Garcia-Garcia HM, Garg S, et al,. The assessment of Shin's method for the prediction of creatinine kinase-MB elevation after percutaneous coronary intervention: An intravascular ultrasound study. Int J Cardiovasc Imaging 2011; 27: 883-892.
14. Kawamoto T, Okura H, Koyama Y, et al,. The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. JACC 2007; 50: 1635-1640.
15. Mangiacapra F, Barbato E, Patti G, et al,. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2010; 3: 318-323.
16. Gulmez O, Yildirir A, Kaynar G, et al,. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions. J Thromb Thrombolysis 2008; 25: 239-246.
17. Talarico GP, Brancati M, Burzotta F, et al,. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: The 'OPTI MIZE-IT' pilot randomized study. J Cardiovasc Med (Hagerstown) 2009; 10: 245-251.
18. Hoole SP, Heck PM, Sharples L, et al,. Coronary stent length predicts PCI-induced cardiac myonecrosis. Coron Artery Dis 2010; 21: 312-317.
19. Radulescu B, Morel O, Faure A, et al,. Myonecrosis and inflammatory response following percutaneous coronary angioplasty. A protective role for betablockers Ann Cardiol Angeiol (Paris) 2009; 58: 27-33.